Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Interventional
×
MOC31PE immunotoxin
×
Clear all
Filters
3
NCT02219893
2017-05-30
ImmunoPeCa
Oslo University Hospital
Phase 1/2
Completed
15 enrolled